Use of α‐synuclein seed amplification assays to assess how clinical features relate to the diagnosis of Dementia with Lewy Bodies.

MLA

Middleton, John, et al. “Use of Α‐synuclein Seed Amplification Assays to Assess How Clinical Features Relate to the Diagnosis of Dementia with Lewy Bodies.” Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, vol. 19, Dec. 2023, pp. 1–2. EBSCOhost, https://doi.org/10.1002/alz.078103.

APA

Middleton, J., MacLeod, K. R., Bozoki, A., Galvin, J. E., Irwin, D. J., Lippa, C., Litvan, I., Lopez, O. L., Berman, S., Tsuang, D. W., Zabetian, C. P., Honig, L. S., Marder, K., Fleisher, J. E., Sabbagh, M., Wint, D., Taylor, A., Bekris, L. M., Leverenz, J. B., & Galasko, D. R. (2023). Use of α‐synuclein seed amplification assays to assess how clinical features relate to the diagnosis of Dementia with Lewy Bodies. Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, 19, 1–2. https://doi.org/10.1002/alz.078103

Chicago

Middleton, John, Karen R MacLeod, Andrea Bozoki, James E Galvin, David J Irwin, Carol Lippa, Irene Litvan, et al. 2023. “Use of Α‐synuclein Seed Amplification Assays to Assess How Clinical Features Relate to the Diagnosis of Dementia with Lewy Bodies.” Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association 19 (December): 1–2. doi:10.1002/alz.078103.